万辰集团: 华兴证券有限公司关于福建万辰生物科技集团股份有限公司本次交易符合《创业板上市公司持续监管办法（试行）》第十八条和《深圳证券交易所上市公司重大资产重组审核规则》第八条规定的说明

Group 1 - The company, Fujian Wancheng Biotechnology Group Co., Ltd., plans to acquire minority stakes in Nanjing Wanyou Commercial Management Co., Ltd. through cash payment, constituting a major asset restructuring [1][2] - The transaction aims to enhance the company's control over its subsidiaries, improve overall governance, and align with the company's long-term development strategy, thereby increasing its competitive strength [2] - The target company's main business is retail snack sales, which aligns with the company's primary business of retail snack sales and the research, cultivation, and sales of edible fungi, both classified under "F52 Retail" in the national economic industry classification [2]